What's New?
| January 2008 | I-MED Pharma and Addition Technologies are pleased to announce that Intacs® have now been approved by Health Canada for implantation and correction of keratoconus |
| August 2007 | I-MED Pharma is pleased to announce that it is the exclusive Canadian distributor for Rayner intraocular lenses. In 1949 British surgeon, Sir Harold Ridley asked Rayner to design and produce the first IOL. Since this pioneering work in the restoration of sight, Rayner has worked with surgeons around the world in the continued development of the IOL. The C-flex® acrylic IOL is now approved by Health Canada for implantation following cataract surgery. |
| January 2007 | I-MED Pharma is pleased to announce that it is launching the the Optyse™ Lens Free Ophthalmoscope which will revolutionize the use of direct ophthalmoscopy in veterinary medicine. This instrument will be exhibited at the North American Veterinary Conference in Orlando Florida on January 13-17th, 2007 |
| October 2006 | I-MED Pharma is pleased to announce that is is launching another first in ophthalmic human and veterinary dry eye treatment, I-Drop®PM and I-Drop®VetPLUS viscoadaptive non-preserved eye drops offering the longest relief from symptoms of dry eye. |
| September 2006 | I-MED Pharma is pleased to announce that it has been selected to be the exclusive Canadian distributor for the Optonol ExPRESS® Mini Glaucoma Shunt |
| September 2006 | I-MED Pharma is pleased to announce that it has been selected to be the exclusive Canadian distributor for the Addition Technologies, Inc. Intacs® Corneal Implants |
| November 2005 | I-MED Pharma is pleased to announce the launch of the new I-Drop® the long-lasting dry eye and ocular discomfort solutions for day time and contact lens use |
| October 2005 | I-MED Pharma is pleased to announce the launch of the Moria DSAEK System on the Canadian market |
| May 2005 | I-MED Pharma is pleased to announce the launch of the Moria Epi-K system on the Canadian market |
January 2005 |
I-MED Pharma is pleased to announce the launch of the OERTLI CataRhex® SwissTech Phaco system on the Canadian market |
January 2005 |
I-MED Pharma is pleased to announce the launch of the Moria EVOLUTION 3 Microkeratome console on the Canadian market |
December 2003 |
I-MED Pharma is pleased to announce the launch of the Moria M2 ONE USE on the Canadian market |
October 2003 |
I-MED Pharma is pleased to announce the launch of the OS3 COOL Phaco on the Canadian market |
| October 2003 | I-MED Pharma is pleased to announce the launch of I-Drop® and I-Drop®PM the first long-lasting dry eye and ocular discomfort solutions for day and night -time use |
June 2003 |
I-MED Pharma is pleased to announce that it has signed a multi-year agreement with Laboratoires Théa S.A. of Clermont-Ferrand, France to represent SICCAFLUID®, LARMABAK® and BLEPHAGEL® on the Canadian market |
| October 2001 | I-MED Pharma is pleased to announce the launch of the OS3 on the Canadian market |
| October 2001 | I-MED Pharma is pleased to announce the launch of the SmartPLUG® |
| October 2000 | I-MED Pharma has been appointed the exclusive Canadian Distributor for Ciba Surgical Division products. |
| May 2000 | I-MED Pharma has been appointed the exclusive North American distributor for the CANI/JAG foldable canine manufactured by Laboratoires IOLTECHnologie SA of France. |
| April 2000 | I-MED Pharma has been appointed the Exclusive Canadian Distributor for the Odyssey products including its patented PARASOL® Punctal Occluder. These products are now fully approved for sale in Canada |